Document is current
Any future updates will be listed below
-
Authors
Cui, Wanyuan https://orcid.org/0000-0002-5077-6814
Popat, Sanjay https://orcid.org/0000-0003-2087-4963
- License Information
-
More Information
Article History
Accepted: 17 March 2021
First Online: 9 June 2021
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Dr Cui reports research grant funding from the Breast Cancer Trials group and the Australian Government Research Training scholarship, outside of the submitted work. Prof. Popat reports personal fees from AstraZeneca, Roche, Boehringer Ingelheim, Pfizer, Novartis, Takeda, BMS, MSD, EMD Serono, Bayer, Blueprint, Daiichi Sankyo, Guardant Health, Janssen, GSK, BeiGene, Incyte, Eli Lilly, Amgen, outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: WC literature search, tables, data interpretation, writing. SBP data interpretation, writing, supervision.
